September 25, 2012

Valeant Pharmaceuticals International has acquired rights to a drug used to treat a symptom of age-related macular degeneration, the drug maker said.

September 25, 2012

Generic drug maker Watson Labs recalled two lots of a prescription painkiller due to the potential for oversized and overly potent tablets, the company said.

September 24, 2012

The Food and Drug Administration has approved a drug for treating a complication of a disease that results from vein blockages in the eye.

September 21, 2012

The pharmaceuticals business will begin picking up in 2014, AmerisourceBergen president and CEO Steve Collis said at the wholesaler's ThinkLive Manufacturer's Summit.

September 21, 2012

The Food and Drug Administration has approved a new usage for an Amgen drug, the drug maker said.

September 21, 2012

The Arizona Corporate Excellence Awards has named Avella Specialty Pharmacy as the fastest-growing private company based in the state, Avella said.

September 20, 2012

Atlanta-based reproductive and sexual health organization SisterLove and drug maker Merck have collaborated to create a mini-documentary and educational HIV/AIDS treatment and care resource.

September 20, 2012

A nonprofit organization that will be dedicated to representing all specialty pharmacy stakeholders and providing a voice in the specialty pharmacy industry will make its debut in October.

September 14, 2012

The specialty pharmacy operated by Omnicare Specialty Care Group has been added to the limited distribution network for a drug used to treat a hereditary degenerative disorder.

September 13, 2012

The Food and Drug Administration has approved a new drug for multiple sclerosis.

September 12, 2012

Drug maker Johnson & Johnson said Wednesday that patients applying for its HIV drug assistance program would have a more streamlined application process.

September 7, 2012

BioPlus announced that Fred Gagle has joined the company as VP information technology.

September 6, 2012

A panel of Food and Drug Administration experts is recommending that the agency approve an experimental drug for cystic fibrosis made by Novartis, the Swiss drug maker said.

September 6, 2012

Walgreens will offer products and other resources for women who have fertility complications due to cancer treatment, under a partnership with Ferring Pharmaceuticals announced Thursday.

September 5, 2012

A safety-net healthcare organization in Colorado got a donation of four new vaccine refrigerators at the end of a recent trade show there.

September 5, 2012

Bayer HealthCare and Onyx Pharmaceuticals are seeking approval for a new drug to treat tumors of the gut, the companies said.

September 5, 2012

The Food and Drug Administration has approved a new drug for treating a rare blood and marrow cancer that affects older adults, the agency said Tuesday.

September 5, 2012

The Food and Drug Administration will not decide whether to approve a drug for diarrhea in HIV patients as it continues to review the regulatory approval application for it, the drug's manufacturer said.

September 4, 2012

The Food and Drug Administration has approved a new drug made by Astellas Pharma U.S. and Medivation for treating prostate cancer, the agency said Friday.

September 4, 2012

The Food and Drug Administration has approved a new formulation of a cancer drug made by Novartis for a type of brain cancer in children, the agency said.

September 4, 2012

Generic drug maker Impax Labs has settled with a subsidiary of Sanofi regarding generic versions of two drugs for dialysis patients, Impax said Tuesday.

August 30, 2012

Specialty pharmacy is one of the fastest-growing segments of pharmacy today, but only a minority of specialty drugs that end up in patients' hands are dispensed through retail pharmacy channels.

August 30, 2012

The Food and Drug Administration has approved a biosimilar drug made by Teva Pharmaceutical Industries for a condition that results from certain chemotherapy treatments, the drug maker said Thursday.

August 29, 2012

Community Specialty Pharmacy Network has appointed a former Bayer Pharmaceuticals executive to serve as the organization's VP managed care relations.